BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clonal and is caused mostly by transmission. Identifying transmission chains is important in controlling DR-TB. This study reports on the sentinel molecular surveillance data of Rifampicin-Resistant (RR) TB in SA, aiming to describe the RR-TB strain population and the estimated transmission of RR-TB cases. METHOD: RR-TB isolates collected between 2014 and 2018 from eight provinces were genotyped using combination of spoligotyping and 24-loci mycobacterial interspersed repetitive-units-variable-number tandem repeats (MIRU-VNTR) typing. RESULTS: Of the 3007 isolates genotyped, 301 clusters were identified. Cluster size ranged between 2 and 2...
BACKGROUND: Tuberculosis (TB) is the leading infectious cause of death globally, and drug-resistant ...
Global roll-out of rapid molecular assays is revolutionising the diagnosis of rifampicin resistance,...
The relative contribution of reactivated and recently acquired tuberculosis to the disease burden in...
BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clon...
SETTING: The epidemiology of extensively drug-resistant tuberculosis (XDR-TB), an emerging threat to...
OBJECTIVE: Although little studied in developing countries, multidrug-resistant tuberculosis (MDR-TB...
Background: According to the World Health Organization Global TB report 2018, rifampicin monoresista...
Background: In 2005 a cluster of 53 HIV-infected patients with extensively drug-resistant tuberculos...
Abstract Background Drug-resistant tuberculosis (DR-TB) epidemic is driven mainly by the effect of o...
Background: Recent gains in TB control in South Africa are being reversed by drug-resistant tubercul...
Thesis (M.Med.)-University of KwaZulu-Natal, Durban, 2011.Mycobacterium tuberculosis (MTB) is an air...
South Africa is experiencing a widespread drug-resistant tuberculosis epidemic, although data are li...
Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) is a serious problem...
BACKGROUND:South Africa has the highest tuberculosis incidence globally (781/100,000), with an estim...
Background: South Africa has the highest tuberculosis incidence globally (781/100,000), with an esti...
BACKGROUND: Tuberculosis (TB) is the leading infectious cause of death globally, and drug-resistant ...
Global roll-out of rapid molecular assays is revolutionising the diagnosis of rifampicin resistance,...
The relative contribution of reactivated and recently acquired tuberculosis to the disease burden in...
BACKGROUND: Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clon...
SETTING: The epidemiology of extensively drug-resistant tuberculosis (XDR-TB), an emerging threat to...
OBJECTIVE: Although little studied in developing countries, multidrug-resistant tuberculosis (MDR-TB...
Background: According to the World Health Organization Global TB report 2018, rifampicin monoresista...
Background: In 2005 a cluster of 53 HIV-infected patients with extensively drug-resistant tuberculos...
Abstract Background Drug-resistant tuberculosis (DR-TB) epidemic is driven mainly by the effect of o...
Background: Recent gains in TB control in South Africa are being reversed by drug-resistant tubercul...
Thesis (M.Med.)-University of KwaZulu-Natal, Durban, 2011.Mycobacterium tuberculosis (MTB) is an air...
South Africa is experiencing a widespread drug-resistant tuberculosis epidemic, although data are li...
Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) is a serious problem...
BACKGROUND:South Africa has the highest tuberculosis incidence globally (781/100,000), with an estim...
Background: South Africa has the highest tuberculosis incidence globally (781/100,000), with an esti...
BACKGROUND: Tuberculosis (TB) is the leading infectious cause of death globally, and drug-resistant ...
Global roll-out of rapid molecular assays is revolutionising the diagnosis of rifampicin resistance,...
The relative contribution of reactivated and recently acquired tuberculosis to the disease burden in...